Related Experiment Video

Updated: Apr 12, 2026

An Orthotopic Murine Model of Human Prostate Cancer Metastasis
06:48

An Orthotopic Murine Model of Human Prostate Cancer Metastasis

Published on: September 18, 2013

36.2K

The TGF-β Signaling Regulator PMEPA1 Suppresses Prostate Cancer Metastases to Bone

Pierrick G J Fournier1, Patricia Juárez1, Guanglong Jiang2

  • 1Division of Endocrinology, Indiana University School of Medicine, Indianapolis, IN 46202, USA; Division of Endocrinology, University of Virginia School of Medicine, Charlottesville, VA 22903, USA.

Cancer Cell
|May 19, 2015
PubMed

Insights

Transforming growth factor-β (TGF-β) signaling drives prostate cancer bone metastasis. Inhibiting TGF-β receptor 1 (TGFBR1) with SD208 and understanding PMEPA1

Area of Science:

  • Oncology
  • Molecular Biology
  • Cancer Metastasis Research

Background:

  • Transforming growth factor-β (TGF-β) is implicated in breast cancer bone metastasis, but its role in prostate cancer bone metastasis is less understood.
  • Prostate cancer frequently metastasizes to bone, significantly impacting patient prognosis and quality of life.

Purpose of the Study:

  • To investigate the role of TGF-β signaling in prostate cancer bone metastasis.
  • To evaluate the efficacy of TGFBR1 inhibition in reducing prostate cancer bone metastases.
  • To identify key genes regulated by TGF-β in prostate cancer and their association with metastasis.

Main Methods:

  • Utilized a TGFBR1 inhibitor (SD208) to treat prostate cancer models.
  • Analyzed gene expression changes in prostate cancer cells upon TGF-β stimulation.
  • Assessed PMEPA1 expression in patient samples and correlated it with clinical outcomes.
  • Investigated the interaction of PMEPA1 isoforms with signaling proteins using molecular assays.
  • Employed a mouse model to study the effect of PMEPA1 knockdown on bone metastasis.

Main Results:

  • The TGFBR1 inhibitor SD208 demonstrated efficacy in reducing prostate cancer bone metastases.
  • TGF-β upregulates genes associated with cancer aggressiveness and bone metastasis, with PMEPA1 being the most significantly upregulated.
  • Decreased PMEPA1 expression was observed in metastatic prostate cancer patients, and low PMEPA1 levels correlated with reduced metastasis-free survival.
  • Membrane-anchored PMEPA1 isoforms inhibit TGF-β signaling by interacting with R-SMADs and ubiquitin ligases, independent of proteasomal degradation.
  • PMEPA1 knockdown enhanced prometastatic gene expression and increased bone metastases in a mouse model, indicating its role as a negative feedback regulator.

Conclusions:

  • TGF-β signaling is a critical driver of prostate cancer bone metastasis.
  • Targeting TGFBR1 with inhibitors like SD208 shows therapeutic potential.
  • PMEPA1 acts as a tumor suppressor in prostate cancer bone metastasis by negatively regulating TGF-β signaling, and its loss promotes metastasis.

More Related Videos

Studying TGF-β Signaling and TGF-β-induced Epithelial-to-mesenchymal Transition in Breast Cancer and Normal Cells06:54

Studying TGF-β Signaling and TGF-β-induced Epithelial-to-mesenchymal Transition in Breast Cancer and Normal Cells

Published on: October 27, 2020

14.9K
Intra-Cardiac Injection of Human Prostate Cancer Cells to Create a Bone Metastasis Xenograft Mouse Model06:32

Intra-Cardiac Injection of Human Prostate Cancer Cells to Create a Bone Metastasis Xenograft Mouse Model

Published on: November 4, 2022

7.4K

Related Concept Videos

TGF - β Signaling Pathway01:16

TGF - β Signaling Pathway

The TGF-β signaling pathway regulates cell growth, differentiation, adhesion, motility, and development. TGF-β ligands that induce TGF-β signaling are synthesized in their latent form. Several proteases or cell surface receptors such as integrins act upon the latent form, releasing the active ligand. There are three types of mammalian TGF-βs: (TGF-β1, TGF-β2, and TGF-β3) that bind as homodimers or heterodimers to TGF-β receptors. The TGF-β receptors...
11.0K
Mitogens and the Cell Cycle02:38

Mitogens and the Cell Cycle

Mitogens and their receptors play a crucial role in controlling the progression of the cell cycle. However, the loss of mitogenic control over cell division leads to tumor formation. Therefore, mitogens and mitogen receptors play an important role in cancer research. For instance, the epidermal growth factor (EGF) - a type of mitogen and its transmembrane receptor (EGFR), decides the fate of the cell's proliferation. When EGF binds to EGFR, a member of the ErbB family of tyrosine kinase...
8.5K
Abnormal Proliferation02:23

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
5.4K
Regulation of Angiogenesis and Blood Supply01:24

Regulation of Angiogenesis and Blood Supply

Rapidly dividing tumors, embryos, and wounded tissues require more oxygen than usual, lowering the oxygen concentration in the blood. At low oxygen or hypoxic conditions, an oxygen-sensitive transcription factor called the hypoxia-inducible factor 1 or HIF1 is activated. HIF1 is a dimeric protein of alpha (ɑ) and beta (β) subunits.  Under optimal oxygen conditions, HIF1β is present in the nucleus while HIF1ɑ remains in the cytosol. HIF1ɑ is hydroxylated by prolyl...
4.0K
Master Transcription Regulators02:23

Master Transcription Regulators

Master transcription regulators are regulatory proteins that are predominantly responsible for regulating the expression of multiple genes. Often these genes work in concert to drive a  complex process. Activation of a master transcription regulator can lead to a cascade of transcriptional activation necessary for that outcome. These regulators can directly bind to the regulatory sequences of the various genes involved, or they can indirectly regulate transcription by binding to regulatory...
8.0K
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
5.1K